These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29440136)

  • 1. Problems in anticoagulation of a patient with antibiotic treatment for endocarditis: interaction of rifampicin and vitamin K antagonists.
    Mizera L; Geisler T; Mörike K; Gawaz M; Steeg M
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29440136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prolonged diminished effect of coumarin derivatives after use of rifampicin].
    Harmsze AM; Deneer VH; Wiltink EH
    Ned Tijdschr Geneeskd; 2007 Sep; 151(35):1945-9. PubMed ID: 17907547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical heart valve recipients: anticoagulation in patients with genetic variations of phenprocoumon metabolism.
    Brehm K; Schack J; Heilmann C; Blanke P; Geissler HJ; Beyersdorf F
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):309-14; discussion 314-5. PubMed ID: 23423913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.
    Ufer M
    Clin Pharmacokinet; 2005; 44(12):1227-46. PubMed ID: 16372822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticoagulation during pregnancy following an artificial heart valve replacement].
    Strecker T; Zimmermann I; Schlüter G; Feyrer R
    Dtsch Med Wochenschr; 2009 Oct; 134(42):2116-9. PubMed ID: 19809961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation.
    Bertram M; Bonsanto M; Hacke W; Schwab S
    J Neurol; 2000 Mar; 247(3):209-14. PubMed ID: 10787117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginger-associated overanticoagulation by phenprocoumon.
    Krüth P; Brosi E; Fux R; Mörike K; Gleiter CH
    Ann Pharmacother; 2004 Feb; 38(2):257-60. PubMed ID: 14742762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive anticoagulation with warfarin or phenprocoumon may have multiple causes.
    Meegaard PM; Holck LH; Pottegård A; Madsen H; Hallas J
    Dan Med J; 2012 Feb; 59(2):A4383. PubMed ID: 22293053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in International Normalized Ratio Among Patients Treated With Dicloxacillin and Vitamin K Antagonists.
    Pottegård A; Henriksen DP; Madsen KG; Hellfritzsch M; Damkier P; Stage TB
    JAMA; 2015 Jul; 314(3):296-7. PubMed ID: 26197191
    [No Abstract]   [Full Text] [Related]  

  • 10. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants.
    Visser LE; Penning-van Bees FJ; Kasbergen AA; De Smet PA; Vulto AG; Hofman A; Stricker BH
    Thromb Haemost; 2002 Nov; 88(5):705-10. PubMed ID: 12428081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Derailed oral anticoagulation with very high INR values and poor response to oral vitamin K--cholestasis as a possible cause].
    Fontana S; Zeerleder S; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):477-80. PubMed ID: 10517112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenprocoumon-induced necrotizing hepatitis].
    Schneider AR; Hartmann D; Arnold JC; Bohrer MH; Riemann JF
    Dtsch Med Wochenschr; 2001 Apr; 126(16):457-9. PubMed ID: 11360450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medial calcific sclerosis under long-term anticoagulation with vitamin K antagonists].
    Walther B
    Dtsch Med Wochenschr; 2013 May; 138(21):1102-6. PubMed ID: 23677504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outpatient anticoagulation].
    Pötzsch B
    MMW Fortschr Med; 2014 May; 156(9):48-53; quiz 54-5. PubMed ID: 24908890
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenprocoumon and acenocoumarol treatment in paediatric patients.
    Spoor N; Smiers FJ; van der Meer FJ; Hutten BA; van Ommen CH
    Thromb Haemost; 2012 Dec; 108(6):1238-41. PubMed ID: 23014894
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
    Beinema M; Brouwers JR; Schalekamp T; Wilffert B
    Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The interaction between anticoagulant therapy with vitamin K-antagonists and treatment with antibiotics: a practical recommendation].
    Zelis M; Zweegman S; van der Meer FJ; Kramer MH; Smulders YM
    Ned Tijdschr Geneeskd; 2008 May; 152(18):1042-6. PubMed ID: 18547025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenprocoumon from a neurosurgical perspective.
    Sandvoss G; Erdlenbruch W; Krischek B
    Semin Thromb Hemost; 1999; 25(1):73-7. PubMed ID: 10327224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.